Irving, Texas — According to state and local economic development sources Caris Life Sciences plans to invest $16,000,000.00 to build out 57,000 square feet of new space in Irving. The company plans to occupy the new space at 3600 W Royal Lane in Irving, on or about November 1, 2020. According to the company website Caris Life Sciences was founded because of an idea that personalized and precise information can improve healthcare for everyone. As an innovative biotechnology company, we’re actively working to fulfill the promise of precision medicine through our unique and transformative platforms to help patients with cancer and other complex diseases. ADAPT Biotargeting System is an unbiased profiling platform that identifies novel molecular targets to inform and enhance drug development and advanced diagnostics. Currently being developed for cancer and other complex diseases, the ADAPT Biotargeting System has potential applications spanning therapeutic development, drug delivery, diagnostics and disease monitoring.

To learn more about Caris Life Sciences, visit http://www.carislifesciences.com/

Company Contact:
David Halbert, Chief Executive Officer
866-771-8946

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved